Gehan Elassal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gehan Elassal has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Amin Abdel Baki
Department Hepatology, Gastroenterology and Infectious diseases National Hepatology and Tropical Medicine Research Institute NHTMRI, Cairo, Egypt
4 shared publications - Mohamed Hassany
Ministry of Health and Population, Cairo, Egypt
4 shared publications - Noha Asem
Department of Public Health and Community Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
4 shared publications - Samy Zaky
Al-Azhar University, Cairo, Egypt
4 shared publications - Ahmad Said Abdalmohsen
Faculty of Medicine Cairo University, Cairo, Egypt
3 shared publications Akram Abdelbary
Critical Care Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt
3 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 139
Patterns and predictors of post COVID-19 pulmonary sequelae
Background: Coronavirus disease 2019 (COVID-19) is an illness by the coronavirus that causes severe acute respiratory syndrome 2 (SARS-CoV-2), mainly impacting the lungs to different degrees. Purpose: Investigation the symptoms of post-COVID-19 sequelae in patients aged ≥ 18 years, with pulmonary manifestations as interstitial lung disease (ILD), pulmonary vascular disease, airway disease, and pleural disorders. Methods: This cross-sectional observational study enrolled 116 participants with validated COVID-19 tests by polymerase chain reaction (PCR). History taking, medical examination, laboratory tests, pulmonary function evaluation, oxygen saturation test, computed tomography (CT) chest assessment, cardiac analyses, electrocardiogram and echocardiogram were performed. Results: The mean age was 50.66 ± 30.07 years, and 68 (58.62%) participants were male. The most common reported symptoms were cough and chest pain, each occurring in 71 (61.21%) patients, followed by dyspnea in 53 (45.69%) participants. On chest CT, fibrosis with air trapping was the most frequently observed finding, occurring in 27 (23.28%) participants, followed by wedge-shaped lesions in 25 (21.55%), bilateral ground-glass opacities in 19 (16.38%), and subpleural reticulations in 18 (15.52%). Myocarditis was the most frequent post-COVID-19 complication, occurring in 42 (36.2%) participants, followed by ILD. In 18 (15.52%) patients and organizing pneumonia in 15 (12.9%) participants. Pulmonary embolism was identified in 9 (7.76%) participants. The distribution of post-COVID-19 complications differed significantly according to the severity of the initial COVID-19 infection ( P < 0.0001). Conclusions: Post-COVID-19 pulmonary sequelae, especially ILD, were frequent and significantly associated with greater acute COVID-19 severity, emphasizing the need for follow-up of severely affected individuals.
- 14 September 2026
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 139
Open AccessPatterns and predictors of post COVID-19 pulmonary sequelae
Background: Coronavirus disease 2019 (COVID-19) is an illness by the coronavirus that causes severe acute respiratory syndrome 2 (SARS-CoV-2), mainly impacting the lungs to different degrees. Purpose: Investigation the symptoms of post-COVID-19 sequelae in patients aged ≥ 18 years, with pulmonary manifestations as interstitial lung disease (ILD), pulmonary vascular disease, airway disease, and pleural disorders. Methods: This cross-sectional observational study enrolled 116 participants with validated COVID-19 tests by polymerase chain reaction (PCR). History taking, medical examination, laboratory tests, pulmonary function evaluation, oxygen saturation test, computed tomography (CT) chest assessment, cardiac analyses, electrocardiogram and echocardiogram were performed. Results: The mean age was 50.66 ± 30.07 years, and 68 (58.62%) participants were male. The most common reported symptoms were cough and chest pain, each occurring in 71 (61.21%) patients, followed by dyspnea in 53 (45.69%) participants. On chest CT, fibrosis with air trapping was the most frequently observed finding, occurring in 27 (23.28%) participants, followed by wedge-shaped lesions in 25 (21.55%), bilateral ground-glass opacities in 19 (16.38%), and subpleural reticulations in 18 (15.52%). Myocarditis was the most frequent post-COVID-19 complication, occurring in 42 (36.2%) participants, followed by ILD. In 18 (15.52%) patients and organizing pneumonia in 15 (12.9%) participants. Pulmonary embolism was identified in 9 (7.76%) participants. The distribution of post-COVID-19 complications differed significantly according to the severity of the initial COVID-19 infection ( P < 0.0001). Conclusions: Post-COVID-19 pulmonary sequelae, especially ILD, were frequent and significantly associated with greater acute COVID-19 severity, emphasizing the need for follow-up of severely affected individuals.
- 28 December 2021
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 17 (12) , 1473-1480
Utility of Lung Ultrasound in Decision-making to Prioritize Hospital Admission for COVID-19 Patients: A Developing Country Perspective
Background & Aims: In healthcare settings with limited resources, it is crucial to make a plan to prioritize hospital admission for patients affected by COVID-19. So, we tried to develop a novel approach for triaging COVID-19 patients and deciding the priority for hospital admission using Lung Ultrasound. In this study, we aimed to evaluate the efficacy of lung ultrasound in triaging suspected COVID-19 patients and assessment of the severity of COVID-19 pneumonia and its comparison with CT chest as the gold standard. Method: This was a multicenter cross-sectional study enrolled on 243 COVID-19 confirmed patients presented to the emergency department in three major University hospitals in Egypt. Lung ultrasound was done by an experienced emergency physician or chest physician according to the local protocol of each hospital. Demographic, clinical, and laboratory data were collected from each patient. Each patient was subjected to CT chest and lung ultrasound. Results: A total of 243 confirmed COVID-19 patients were enrolled in this study, with a mean age of 46.7+10.4 years. Ground glass opacity (GGO), subpleural consolidation, trans-lobar consolidation, and crazy paving were reported in chest CT scans of 54.3%, 15.2%, 11.1%, and 8.6% of patients, respectively. B-line artifacts were found in 81.1% of COVID-19 patients, which was of confluent pattern in 18.9% of patients. The lung ultrasound findings of 197 patients (81.1%) were completely coincident with those of CT with a Kappa agreement value of 0.77, and this offered a diagnostic sensitivity of 74 %, a diagnostic specificity of 97.9 %, positive predictive value (PPV) of 90.2% and negative predictive value (NPV) of 93.6 % for lung ultrasound in triaging COVID-19 patients. Adding O2 saturation to the findings of lung imaging, the accuracy of evaluation of lung ultrasound to differentiate between severe and non-severe lung diseases showed that ultrasound had 100% sensitivity and specificity. Conclusion: Lung Ultrasound with Oxygen saturation is a very efficient tool for decision-making to prioritize hospital admission for patients affected by COVID-19 in healthcare settings with limited resources.
- 28 December 2021
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 17 (12) , 1473-1480
Utility of Lung Ultrasound in Decision-making to Prioritize Hospital Admission for COVID-19 Patients: A Developing Country Perspective
Background & Aims: In healthcare settings with limited resources, it is crucial to make a plan to prioritize hospital admission for patients affected by COVID-19. So, we tried to develop a novel approach for triaging COVID-19 patients and deciding the priority for hospital admission using Lung Ultrasound. In this study, we aimed to evaluate the efficacy of lung ultrasound in triaging suspected COVID-19 patients and assessment of the severity of COVID-19 pneumonia and its comparison with CT chest as the gold standard. Method: This was a multicenter cross-sectional study enrolled on 243 COVID-19 confirmed patients presented to the emergency department in three major University hospitals in Egypt. Lung ultrasound was done by an experienced emergency physician or chest physician according to the local protocol of each hospital. Demographic, clinical, and laboratory data were collected from each patient. Each patient was subjected to CT chest and lung ultrasound. Results: A total of 243 confirmed COVID-19 patients were enrolled in this study, with a mean age of 46.7+10.4 years. Ground glass opacity (GGO), subpleural consolidation, trans-lobar consolidation, and crazy paving were reported in chest CT scans of 54.3%, 15.2%, 11.1%, and 8.6% of patients, respectively. B-line artifacts were found in 81.1% of COVID-19 patients, which was of confluent pattern in 18.9% of patients. The lung ultrasound findings of 197 patients (81.1%) were completely coincident with those of CT with a Kappa agreement value of 0.77, and this offered a diagnostic sensitivity of 74 %, a diagnostic specificity of 97.9 %, positive predictive value (PPV) of 90.2% and negative predictive value (NPV) of 93.6 % for lung ultrasound in triaging COVID-19 patients. Adding O2 saturation to the findings of lung imaging, the accuracy of evaluation of lung ultrasound to differentiate between severe and non-severe lung diseases showed that ultrasound had 100% sensitivity and specificity. Conclusion: Lung Ultrasound with Oxygen saturation is a very efficient tool for decision-making to prioritize hospital admission for patients affected by COVID-19 in healthcare settings with limited resources.
- Open Access
- 4 November 2021
- Published by Springer Nature in Journal of the Egyptian Public Health Association
- Vol. 96 (1) , 1-5
Clinical evaluation of pregnant women with SARS-COV2 pneumonia: a real-life study from Egypt
Background: Knowledge about the outcome of COVID-19 on pregnant women is so important. The published literature on the outcomes of pregnant women with COVID-19 is confusing. The aim of this study was to report our clinical experience about the effect of COVID-19 on pregnant women and to determine whether it was associated with increased mortality or an increase in the need for mechanical ventilation in this special category of patients. Methods: This was a cohort study from some isolation hospitals of the Ministry of Health and Population, in eleven governorates, Egypt. The clinical data from the first 64 pregnant women with COVID-19 whose care was managed at some of the Egyptian hospitals from 14 March to 14 June 2020 as well as 114 non-pregnant women with COVID-19 was reviewed. Results: The two groups did not show any significant difference regarding the main outcomes of the disease. Two cases in each group needed mechanical ventilation (p 0.617). Three cases (4.7%) died among the pregnant women and two (1.8%) died among the non-pregnant women (p 0.352). Conclusions: The main clinical outcomes of COVID-19 were not different between pregnant and non-pregnant women with COVID-19. Based on our findings, pregnancy did not exacerbate the course or mortality of COVID-19 pneumonia.
- 4 November 2021
- Published by Springer Nature in Journal of the Egyptian Public Health Association
- Vol. 96 (1) , 1-5
Open AccessClinical evaluation of pregnant women with SARS-COV2 pneumonia: a real-life study from Egypt
Background: Knowledge about the outcome of COVID-19 on pregnant women is so important. The published literature on the outcomes of pregnant women with COVID-19 is confusing. The aim of this study was to report our clinical experience about the effect of COVID-19 on pregnant women and to determine whether it was associated with increased mortality or an increase in the need for mechanical ventilation in this special category of patients. Methods: This was a cohort study from some isolation hospitals of the Ministry of Health and Population, in eleven governorates, Egypt. The clinical data from the first 64 pregnant women with COVID-19 whose care was managed at some of the Egyptian hospitals from 14 March to 14 June 2020 as well as 114 non-pregnant women with COVID-19 was reviewed. Results: The two groups did not show any significant difference regarding the main outcomes of the disease. Two cases in each group needed mechanical ventilation (p 0.617). Three cases (4.7%) died among the pregnant women and two (1.8%) died among the non-pregnant women (p 0.352). Conclusions: The main clinical outcomes of COVID-19 were not different between pregnant and non-pregnant women with COVID-19. Based on our findings, pregnancy did not exacerbate the course or mortality of COVID-19 pneumonia.
- Open Access
Demographic and clinical features associated with in-hospital mortality in Egyptian COVID-19 patients: A retrospective cohort study
Introduction Since the worldwide emergence of the COVID-19, several protocols were used by different healthcare organisations. We evaluated in this study the demographic and clinical characteristics of COVID-19 disease in Egyptian population with special consideration for its mortality predictors. Methodology 8162 participants (mean age 48.7±17.3 years,54.5% males) with RT-PCR positive COVID-19 were included. The electronic medical records were reviewed for demographic, clinical, laboratory, and radiologic features. The primary outcome was the in-hospital mortality rate. Results The in-hospital mortality was 11.2%. There was a statistically significant strong association of in-hospital mortality with age >60 years old (OR:4.7; 95% CI 4.1-5.4;pConclusions This multicenter, retrospective study ascertained the higher in-hospital mortality rate in Egyptian COVID-19 patients with different comorbidities.
Open AccessDemographic and clinical features associated with in-hospital mortality in Egyptian COVID-19 patients: A retrospective cohort study
Introduction Since the worldwide emergence of the COVID-19, several protocols were used by different healthcare organisations. We evaluated in this study the demographic and clinical characteristics of COVID-19 disease in Egyptian population with special consideration for its mortality predictors. Methodology 8162 participants (mean age 48.7±17.3 years,54.5% males) with RT-PCR positive COVID-19 were included. The electronic medical records were reviewed for demographic, clinical, laboratory, and radiologic features. The primary outcome was the in-hospital mortality rate. Results The in-hospital mortality was 11.2%. There was a statistically significant strong association of in-hospital mortality with age >60 years old (OR:4.7; 95% CI 4.1-5.4;pConclusions This multicenter, retrospective study ascertained the higher in-hospital mortality rate in Egyptian COVID-19 patients with different comorbidities.
- 1 February 2021
- Published by Georg Thieme Verlag KG in Journal of Pediatric Infectious Diseases
- Vol. 16 (02) , 057-061
COVID-19 in Egyptian Children: A Multicenter Study
Objective The novel coronavirus disease 2019 (COVID-19) has made its worldwide spread since its outbreak in December 2019. Limited information is available about the epidemiology and clinical characteristics of COVID-19, especially in Africa and Egypt. Methods We aimed to study the clinical and epidemiological characteristics of COVID-19 in Egyptian children. This is an observational retrospective cohort study performed at two specialized COVID-19 isolation hospitals in Egypt. All admitted COVID-19 pediatric patients between March 20, 2020, and May 1, 2020, were included in the study. Discussion This study included 40 COVID-19 confirmed cases (mean age, 9.4 years), 67.5% were male, 85% were asymptomatic, and 15% had mild symptoms. There were no confirmed severe or critically ill cases among the patients. Conclusion COVID-19 runs in a benign course in Egyptian children with no mortality and no significant morbidity.
- 1 February 2021
- Published by Georg Thieme Verlag KG in Journal of Pediatric Infectious Diseases
- Vol. 16 (02) , 057-061
COVID-19 in Egyptian Children: A Multicenter Study
Objective The novel coronavirus disease 2019 (COVID-19) has made its worldwide spread since its outbreak in December 2019. Limited information is available about the epidemiology and clinical characteristics of COVID-19, especially in Africa and Egypt. Methods We aimed to study the clinical and epidemiological characteristics of COVID-19 in Egyptian children. This is an observational retrospective cohort study performed at two specialized COVID-19 isolation hospitals in Egypt. All admitted COVID-19 pediatric patients between March 20, 2020, and May 1, 2020, were included in the study. Discussion This study included 40 COVID-19 confirmed cases (mean age, 9.4 years), 67.5% were male, 85% were asymptomatic, and 15% had mild symptoms. There were no confirmed severe or critically ill cases among the patients. Conclusion COVID-19 runs in a benign course in Egyptian children with no mortality and no significant morbidity.
- Open Access
- 1 October 2014
- Published by Wolters Kluwer Health in The Egyptian Journal of Chest Diseases and Tuberculosis
- Vol. 63 (4) , 1019-1023
Significance of selenium levels in non-small cell lung cancer patients: A comparative study
Selenium is an essential trace element with potent antioxidant activity. It is a natural health product widely used in the treatment and prevention of lung cancers.Aim of workTo assess the selenium levels in the epithelial lining fluid, broncho-alveolar lavage and in the serum of non small cell lung cancer patients in comparison with a healthy smoker group and a healthy non smoker group as the control group.Subjects and methodsFifty candidates participated in this work. They were classified into; 20 patients with non small cell lung cancer, 15 healthy smoker subjects and 15 healthy non smoker subjects as the control group.ResultsThe serum level of selenium was highly significantly lower in non small cell lung cancer patients compared with healthy smokers and healthy non smoker individuals (48.5±9.2, 72±14 and 87±11.3 respectively, P<0.001). The BAL level of selenium was highly significantly lower in non small cell lung cancer patients compared with healthy smokers and healthy non smoker individuals (1.95±0.42, 2.02±0.3 and 2.69±0.2 respectively, P<0.001). Also, the mean concentration of selenium in the epithelial lining fluid was highly significantly lower in non small cell lung cancer patients compared with healthy smokers and healthy non smoker individuals (230±16.4, 289±11.2 and 375.06±15 respectively, P<0.001).ConclusionLower levels of selenium in the serum, BAL and ELF were associated with non small cell lung cancer and to a lesser extent with smokers compared with non smoker healthy individuals
- 1 October 2014
- Published by Wolters Kluwer Health in The Egyptian Journal of Chest Diseases and Tuberculosis
- Vol. 63 (4) , 1019-1023
Open AccessSignificance of selenium levels in non-small cell lung cancer patients: A comparative study
Selenium is an essential trace element with potent antioxidant activity. It is a natural health product widely used in the treatment and prevention of lung cancers.Aim of workTo assess the selenium levels in the epithelial lining fluid, broncho-alveolar lavage and in the serum of non small cell lung cancer patients in comparison with a healthy smoker group and a healthy non smoker group as the control group.Subjects and methodsFifty candidates participated in this work. They were classified into; 20 patients with non small cell lung cancer, 15 healthy smoker subjects and 15 healthy non smoker subjects as the control group.ResultsThe serum level of selenium was highly significantly lower in non small cell lung cancer patients compared with healthy smokers and healthy non smoker individuals (48.5±9.2, 72±14 and 87±11.3 respectively, P<0.001). The BAL level of selenium was highly significantly lower in non small cell lung cancer patients compared with healthy smokers and healthy non smoker individuals (1.95±0.42, 2.02±0.3 and 2.69±0.2 respectively, P<0.001). Also, the mean concentration of selenium in the epithelial lining fluid was highly significantly lower in non small cell lung cancer patients compared with healthy smokers and healthy non smoker individuals (230±16.4, 289±11.2 and 375.06±15 respectively, P<0.001).ConclusionLower levels of selenium in the serum, BAL and ELF were associated with non small cell lung cancer and to a lesser extent with smokers compared with non smoker healthy individuals